Roche raises profit forecast, plans major U.S. investment amid ongoing drug pricing talks.
U.S. and Australia sign critical minerals deal to reduce China's dominance in refining, but local communities raise environmental concerns.
Norfolk Southern's Q3 results show mixed performance, with revenue up but operating expenses and lower insurance recoveries reducing reported net income.
Roche raises profit forecast, plans major U.S. investment amid ongoing drug pricing talks.
U.S. and Australia sign critical minerals deal to reduce China's dominance in refining, but local communities raise environmental concerns.
Norfolk Southern's Q3 results show mixed performance, with revenue up but operating expenses and lower insurance recoveries reducing reported net income.
